{
  "report_rows": [
    {
      "kpi": "Annualized net new bookings",
      "prediction": "MISS",
      "answer": "pred ~$89M vs. cons $93M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$182M vs. cons $174M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$931M vs. cons $929M",
      "confidence": "HIGH"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Revenue",
      "prediction": "LOWER",
      "answer": "guide ~$962M vs. cons $972M (2026Q3)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "LOWER",
      "answer": "guide ~$218M vs. cons $232M (2026Q3)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "LOWER",
      "answer": "guide ~$800M vs. cons $808M (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -7.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -11.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A Q2 EBITDA beat is outweighed by pred ~$89M bookings vs. cons $93M and Q3 EBITDA guide of ~$218M vs. cons $232M; the weaker out-period math should pull second-half estimates down after day 1.",
  "day5_confidence": "MEDIUM"
}